Oct 28, 7:01 AM ET
IDEX reported record third-quarter 2026 net sales of $952 million, up 8% from a year earlier, and diluted EPS of $1.95, up 15%. The company raised its full-year 2026 guidance for organic sales growth and adjusted diluted EPS, which gives shareholders a higher outlook for the year.
- Q3 net sales of $951.7 million rose 8%; organic sales also rose 8%, with orders up 13% to $991.2 million
- Diluted EPS attributable to IDEX was $1.95 versus $1.70; adjusted diluted EPS was $2.33 versus $2.03, up 15%
- Full-year adjusted diluted EPS guidance raised to $8.91 to $8.96 from $8.70 to $8.85
- Full-year organic sales growth guidance raised to 6.5% to 6.8% from 5% to 6%
Read the filing on SEC.gov ↗
Sep 3, 4:06 PM ET
IDEX Corporation amended and restated its credit agreement on September 3, 2026, establishing an $800 million revolving credit facility that matures September 3, 2031, extended from November 1, 2027. The filing describes the facility as a senior unsecured arrangement that can fund working capital, general corporate purposes and refinancing of existing debt, which gives the company longer-dated borrowing capacity.
- Revolving facility of $800 million with final maturity of September 3, 2031, up from November 1, 2027 under the original agreement
- Up to $100 million available for letters of credit and up to $50 million for same-day swingline loans
- Lender commitments may be increased by up to $400 million, and the maturity may be extended twice by one year each
Read the filing on SEC.gov ↗
Aug 17, 4:06 PM ET
IDEX Corporation disclosed that director L. Paris Watts-Stanfield resigned from its Board effective immediately on August 13, 2026. The company said the resignation was not due to any disagreement over its operations, policies or practices. The board size was reduced from ten to nine directors as a result.
- Director L. Paris Watts-Stanfield resigned from the Board effective immediately, with the decision dated August 13, 2026.
- The company stated the resignation was not due to any disagreement on operations, policies or practices.
- Board size was reduced from ten to nine directors.
Read the filing on SEC.gov ↗
Jul 29, 7:01 AM ET
IDEX reported second-quarter 2026 net sales of $921 million, up 6% from a year earlier, and diluted EPS of $1.93, up 11%. The company raised its full-year 2026 organic sales growth guidance to 5% to 6% and its adjusted diluted EPS guidance to $8.70 to $8.85, both above prior ranges, which is a direct positive for shareholders.
- Q2 2026 net sales of $921 million rose 6% reported and 5% organically; adjusted diluted EPS of $2.32 rose 12%.
- Full-year 2026 adjusted diluted EPS guidance raised to $8.70 to $8.85 from $8.35 to $8.55.
- Full-year organic sales growth guidance raised to 5% to 6% from 3% to 4%.
- IDEX returned $77 million through share repurchases and $54 million in dividends in the quarter.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
